Cargando…

Malaria elimination does not cost more than malaria control: Sri Lanka a case in point

BACKGROUND: Malaria was endemic in Sri Lanka for centuries and was eliminated in 2012. It is widely assumed that the costs of elimination are generally greater than that of control. The costs of malaria elimination in Sri Lanka with that of malaria control in the past using periods in which starting...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendis, Kamini, Wickremasinghe, Rajitha, Premaratne, Risintha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344692/
https://www.ncbi.nlm.nih.gov/pubmed/35915503
http://dx.doi.org/10.1186/s12936-022-04249-9
_version_ 1784761272745590784
author Mendis, Kamini
Wickremasinghe, Rajitha
Premaratne, Risintha
author_facet Mendis, Kamini
Wickremasinghe, Rajitha
Premaratne, Risintha
author_sort Mendis, Kamini
collection PubMed
description BACKGROUND: Malaria was endemic in Sri Lanka for centuries and was eliminated in 2012. It is widely assumed that the costs of elimination are generally greater than that of control. The costs of malaria elimination in Sri Lanka with that of malaria control in the past using periods in which starting transmission dynamics were similar were compared. METHODS: The expenditure of the Anti-Malaria Campaign (AMC), total and by budget category, during 2002–2010 is compared with that of malaria control during the period 1980–1989, using regression analyses and the Mann Whitney U statistic. RESULTS: The expenditure on malaria control and malaria elimination was similar ranging from 21 to 45 million USD per year when adjusted for inflation. In both periods, external funding for the malaria progamme constituted around 24% of the total budget; during the control phase in the 1980s, external funds came from bilateral agencies and were disbursed in accordance with government budget guidelines. In the elimination phase in the 2000s, most of external funding was from the Global Fund and had flexibility of disbursement. In the 1980s, most funds were expended on commodities—insecticides, diagnostics and medicines and their delivery; in the elimination phase, they were spent on programme management, human resources, technical assistance and monitoring and evaluation; monitoring and evaluation was not a budget line in the 1980s. Although the cost per case of malaria was considerably higher during the elimination phase than in the control phase, expenditure was not on individual cases but on general systems strengthening. CONCLUSION: Malaria elimination in Southeast Asia may not require more funding than malaria control. But sustained funding for an agile programme with flexibility in fund utilization and improved efficiencies in programme management with stringent monitoring and evaluation appears to be critically important.
format Online
Article
Text
id pubmed-9344692
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93446922022-08-03 Malaria elimination does not cost more than malaria control: Sri Lanka a case in point Mendis, Kamini Wickremasinghe, Rajitha Premaratne, Risintha Malar J Research BACKGROUND: Malaria was endemic in Sri Lanka for centuries and was eliminated in 2012. It is widely assumed that the costs of elimination are generally greater than that of control. The costs of malaria elimination in Sri Lanka with that of malaria control in the past using periods in which starting transmission dynamics were similar were compared. METHODS: The expenditure of the Anti-Malaria Campaign (AMC), total and by budget category, during 2002–2010 is compared with that of malaria control during the period 1980–1989, using regression analyses and the Mann Whitney U statistic. RESULTS: The expenditure on malaria control and malaria elimination was similar ranging from 21 to 45 million USD per year when adjusted for inflation. In both periods, external funding for the malaria progamme constituted around 24% of the total budget; during the control phase in the 1980s, external funds came from bilateral agencies and were disbursed in accordance with government budget guidelines. In the elimination phase in the 2000s, most of external funding was from the Global Fund and had flexibility of disbursement. In the 1980s, most funds were expended on commodities—insecticides, diagnostics and medicines and their delivery; in the elimination phase, they were spent on programme management, human resources, technical assistance and monitoring and evaluation; monitoring and evaluation was not a budget line in the 1980s. Although the cost per case of malaria was considerably higher during the elimination phase than in the control phase, expenditure was not on individual cases but on general systems strengthening. CONCLUSION: Malaria elimination in Southeast Asia may not require more funding than malaria control. But sustained funding for an agile programme with flexibility in fund utilization and improved efficiencies in programme management with stringent monitoring and evaluation appears to be critically important. BioMed Central 2022-08-01 /pmc/articles/PMC9344692/ /pubmed/35915503 http://dx.doi.org/10.1186/s12936-022-04249-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Mendis, Kamini
Wickremasinghe, Rajitha
Premaratne, Risintha
Malaria elimination does not cost more than malaria control: Sri Lanka a case in point
title Malaria elimination does not cost more than malaria control: Sri Lanka a case in point
title_full Malaria elimination does not cost more than malaria control: Sri Lanka a case in point
title_fullStr Malaria elimination does not cost more than malaria control: Sri Lanka a case in point
title_full_unstemmed Malaria elimination does not cost more than malaria control: Sri Lanka a case in point
title_short Malaria elimination does not cost more than malaria control: Sri Lanka a case in point
title_sort malaria elimination does not cost more than malaria control: sri lanka a case in point
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344692/
https://www.ncbi.nlm.nih.gov/pubmed/35915503
http://dx.doi.org/10.1186/s12936-022-04249-9
work_keys_str_mv AT mendiskamini malariaeliminationdoesnotcostmorethanmalariacontrolsrilankaacaseinpoint
AT wickremasingherajitha malariaeliminationdoesnotcostmorethanmalariacontrolsrilankaacaseinpoint
AT premaratnerisintha malariaeliminationdoesnotcostmorethanmalariacontrolsrilankaacaseinpoint